ReviewExperimental hematology & oncology2022

Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential.

Xiao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.